Advances in the Diagnosis and Treatment of Cervical Cancer - Episode 5
Clinical insights on treatment options for patients with newly diagnosed metastatic cervical cancer, with a focus on immunotherapy and the KEYNOTE-826 trial.
Related Content:
Chemo-Radiotherapy Combo May Improve Survival in Advanced Cervical Cancer
FDA Approval Withdrawal of Trodelvy Leaves Fewer Bladder Cancer Options
Sometimes, Cancer Just Gets in My Way
Cyramza-Tagrisso Combo Prolongs PFS in Some Patients With NSCLC Subset